-
Je něco špatně v tomto záznamu ?
A Prospective Comparative Study of Laryngeal Glottic View Using the Vie Scope® versus Standard Macintosh Laryngoscope in Morbidly Obese Patients
T. Gaszynski, P. Michalek, P. Ratajczyk
Status neindexováno Jazyk angličtina Země Nový Zéland
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2005 do Před 4 měsíci
PubMed Central
od 2005
Europe PubMed Central
od 2005
ProQuest Central
od 2005-01-01
Open Access Digital Library
od 2005-01-01
Open Access Digital Library
od 2009-01-01
Taylor & Francis Open Access
od 2005-12-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
Health Management Database (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2005
PubMed
37214351
DOI
10.2147/tcrm.s377585
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
BACKGROUND: The visualization of the glottis may be inadequate in morbidly obese patients when a standard Macintosh blade laryngoscope (MCL) is used. The Vie Scope® (VS) is a novel type laryngoscope consisting of a straight, enclosed, illuminated tube that offers intubation via a bougie using the paraglossal technique. In this prospective, nonrandomized comparative study, we tested the research hypothesis that the VS may improve visualization of the glottic larynx in comparison to the MCL. MATERIALS AND METHODS: After obtaining institutional ethics committee approval, 60 morbidly obese patients (BMI >40 kg/m2) undergoing elective non-head and neck surgery were included in the study. After induction of general anesthesia (GA), the glottic visualization was performed using the two laryngoscopes in succession, first MCL size 3 or 4 followed by the VS and was assessed using the modified Cormack-Lehane scale. Tracheal intubation was performed using the VS The first pass intubation success and the total success rate was recorded only for the VS Intubation time was not measured because of the paired study design. RESULTS AND DISCUSSION: Mean demographic data included: age 41.9±8.2 years, height 171.2±10.2 cm, weight 129.9±21.6 kg, BMI 44.95±3.85 kg/m2. Using MCL, Cormack-Lehane grade 1 was observed in 36 (60%) cases; grade 2 in 7/60 (11.6%); grade 3 in 13/60 (21.7%); and grade 4 in 4/60 (6.7%). Poor laryngeal views represented by grades 3 and 4 were observed in 28.4% of patients with the MCL. Grades obtained with the VS were all grade 1 (100%). The first attempt intubation success was in 58/60 (96.7%) with the VS. No complications were observed. CONCLUSION: The Vie Scope® laryngoscope, using the paraglossal technique of tracheal intubation, significantly improves visualization of the vocal cords in morbidly obese patients compared to the standard Macintosh laryngoscope.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23009762
- 003
- CZ-PrNML
- 005
- 20230721095452.0
- 007
- ta
- 008
- 230707s2023 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2147/TCRM.S377585 $2 doi
- 035 __
- $a (PubMed)37214351
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Gaszynski, Tomasz $u Department of Anaesthesiology and Intensive Therapy, Medical University of Lodz, Lodz, Poland $1 https://orcid.org/0000000152503978
- 245 12
- $a A Prospective Comparative Study of Laryngeal Glottic View Using the Vie Scope® versus Standard Macintosh Laryngoscope in Morbidly Obese Patients / $c T. Gaszynski, P. Michalek, P. Ratajczyk
- 520 9_
- $a BACKGROUND: The visualization of the glottis may be inadequate in morbidly obese patients when a standard Macintosh blade laryngoscope (MCL) is used. The Vie Scope® (VS) is a novel type laryngoscope consisting of a straight, enclosed, illuminated tube that offers intubation via a bougie using the paraglossal technique. In this prospective, nonrandomized comparative study, we tested the research hypothesis that the VS may improve visualization of the glottic larynx in comparison to the MCL. MATERIALS AND METHODS: After obtaining institutional ethics committee approval, 60 morbidly obese patients (BMI >40 kg/m2) undergoing elective non-head and neck surgery were included in the study. After induction of general anesthesia (GA), the glottic visualization was performed using the two laryngoscopes in succession, first MCL size 3 or 4 followed by the VS and was assessed using the modified Cormack-Lehane scale. Tracheal intubation was performed using the VS The first pass intubation success and the total success rate was recorded only for the VS Intubation time was not measured because of the paired study design. RESULTS AND DISCUSSION: Mean demographic data included: age 41.9±8.2 years, height 171.2±10.2 cm, weight 129.9±21.6 kg, BMI 44.95±3.85 kg/m2. Using MCL, Cormack-Lehane grade 1 was observed in 36 (60%) cases; grade 2 in 7/60 (11.6%); grade 3 in 13/60 (21.7%); and grade 4 in 4/60 (6.7%). Poor laryngeal views represented by grades 3 and 4 were observed in 28.4% of patients with the MCL. Grades obtained with the VS were all grade 1 (100%). The first attempt intubation success was in 58/60 (96.7%) with the VS. No complications were observed. CONCLUSION: The Vie Scope® laryngoscope, using the paraglossal technique of tracheal intubation, significantly improves visualization of the vocal cords in morbidly obese patients compared to the standard Macintosh laryngoscope.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Michalek, Pavel $u Department of Anaesthesia and Intensive Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Ratajczyk, Pawel $u Department of Anaesthesiology and Intensive Therapy, Medical University of Lodz, Lodz, Poland
- 773 0_
- $w MED00165795 $t Therapeutics and clinical risk management $x 1176-6336 $g Roč. 19, č. - (2023), s. 405-411
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37214351 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230707 $b ABA008
- 991 __
- $a 20230721095446 $b ABA008
- 999 __
- $a ok $b bmc $g 1958493 $s 1196026
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 19 $c - $d 405-411 $e 20230516 $i 1176-6336 $m Therapeutics and clinical risk management $n Ther. clin. risk manag. $x MED00165795
- LZP __
- $a Pubmed-20230707